Syndex Bio

Seed
syndex.bio AI & Machine Learning Cambridge, United Kingdom
Total Funding $15.5M
Latest Round $15.5M Seed
Last Announced Feb 23, 2026
Investors Undisclosed
Decision Makers 6 Verified

About Syndex Bio

Syndex Bio is a biotechnology platform offering molecular technologies and AI for the diagnosis and treatment of disease.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry AI & Machine Learning
Funding Stage Seed
Global Headquarters Cambridge, United Kingdom
Tracked Since Oct 2, 2026

Web & Domain Identity

Official Website syndex.bio
Domain Registered Date Jan 14, 2022

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $15,500,000 · Seed

    news.google.com

  2. Milestone

    Website domain registered

    syndex.bio

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Syndex Bio.

Funding History

1 Round
Seed equity · Feb 23, 2026
$15,500,000 news.google.com

Founders & Leadership

1

Geoff Smith

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded AI & Machine Learning Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts